Physician

Jeffrey Silver, M.D.

According to 2025 Medicare claims, Jeffrey Silver, M.D. (NPI: 1346210127) practices pulmonary disease in the Rocky Mount, NC market, with the plurality of this provider's patient population coming from Edgecombe, NC. This provider's primary affiliated billing organization is VIDANT MEDICAL GROUP LLC (NPI: 1477648731; TIN: 383740839) and primary practice location at 27886-1935. Silver is affiliated with the Coastal Plains Network, LLC (ACO ID: A2684), participating under the MSSP model.

Silver's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 388 traditional Medicare patients, billed 1,455 HCPCS/CPT codes, and received $108,685 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 658 prescription claims across 170 beneficiaries totaling $397,596 in drug costs, led by Prolastin C (Alpha-1-Proteinase Inhibitor). DME data shows 1,423 claims. Open Payments data shows 8 records totaling $213. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $454,100 to $108,685. Concurrently, Part D prescription costs have changed little. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $287,485 and ending at $130,896.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	817	9,106	$454,100
2016	941	9,416	$519,115
2017	857	8,212	$464,347
2018	796	6,477	$366,356
2019	798	3,995	$291,678
2020	714	3,360	$281,813
2021	565	2,615	$200,658
2022	522	1,884	$143,327
2023	445	1,580	$123,674
2024	388	1,455	$108,685

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	251	2,532	$390,205
2016	216	1,859	$327,160
2017	196	1,216	$310,474
2018	187	1,027	$334,368
2019	164	797	$423,955
2020	151	726	$400,628
2021	141	625	$384,648
2022	118	504	$390,310
2023	129	509	$348,476
2024	170	658	$397,596

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	919	2,784	$283,445
2016	1,126	3,390	$204,469
2017	1,529	4,674	$191,451
2018	1,509	4,130	$206,503
2019	1,477	3,937	$280,549
2020	1,518	4,120	$327,581
2021	1,216	3,223	$274,649
2022	1,017	2,911	$290,461
2023	749	2,170	$228,118
2024	512	1,423	$132,195

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	90	229	$93
94660	Therapy procedure using a positive pressure ventilator	110	130	$49
94729	Test to examine how well the lungs exchange gases	102	105	$37
94727	Test to determine lung volumes using gas dilution or washout	101	104	$29
94618	Test for exercise-induced lung stress	98	105	$24

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prolastin C	Alpha-1-Proteinase Inhibitor	13	364	$128,884
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	121	3,750	$79,238
Nucala	Mepolizumab	17	476	$68,805
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	53	1,590	$34,192
Xolair	Omalizumab	11	308	$27,588

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	39	$39,787
E0465	Home ventilator, any type, used with invasive interface, (e.g., tracheostomy tube)	Y	N/R	26	$26,548
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	35	260	$20,270
A7030	Full face mask used with positive airway pressure device, each	N	46	90	$7,573
A7031	Face mask interface, replacement for full face mask, each	N	45	92	$7,526

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$213	Resmed Corp
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jeffrey Silver, M.D.?

Tedicare shows public-source Medicare data for Jeffrey Silver, M.D. (NPI 1346210127), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey Silver, M.D. have ACO affiliation data?

Jeffrey Silver, M.D. is shown with ACO affiliation data for Coastal Plains Network, LLC (MSSP, ACO ID A2684).

What billing organization is linked to Jeffrey Silver, M.D.?

Jeffrey Silver, M.D. is linked to VIDANT MEDICAL GROUP LLC (billing NPI 1477648731) in the available physician profile data.

Does Jeffrey Silver, M.D. have Open Payments data?

Jeffrey Silver, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.